BIG
RGNX icon

Brooklyn Investment Group’s Regenxbio RGNX Stock Holding History

Brooklyn Investment Group’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,583
Closed -$39.9K – 3399
2025
Q1 		$39.9K Buy
5,583
+3,466
+164% +$25.8K 0.01% 880
2024
Q4 		$16.4K Buy
+2,117
New +$19.9K ﹤0.01% 810

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Brooklyn Investment Group's RGNX Position: Q2 2025 in Review

Brooklyn Investment Group sold out of Regenxbio (RGNX) in Q2 2025, closing a stake of 5,583 shares — an estimated $39.9K sold.

Brooklyn Investment Group first reported a position in RGNX in Q4 2024 and held it in 2 quarters. The position peaked at $39.9K in Q1 2025. 159 funds tracked by Wall St. Rank hold RGNX as of Q2 2025.

  • Brooklyn Investment Group reported no remaining Regenxbio position as of Q2 2025 after selling out during the quarter.
  • Brooklyn Investment Group sold 5,583 Regenxbio shares in Q2 2025, an estimated $39.9K.
  • Brooklyn Investment Group first reported a position in Regenxbio in Q4 2024 and held it in 2 quarters.
  • Brooklyn Investment Group's Regenxbio position peaked at $39.9K in Q1 2025.
  • 159 funds tracked by Wall St. Rank held Regenxbio as of Q2 2025.

Based on Brooklyn Investment Group's 13F filing for Q2 2025, filed 12 Aug 2025.